1887

Abstract

-associated disease (CDAD) is caused by a spore-forming bacterium and can result in highly variable disease, ranging from mild diarrhoea to severe clinical manifestations. Infections are most commonly seen in hospital settings and are often associated with on-going antibiotic therapy. Incidences of CDAD have shown a sustained increase worldwide over the last ten years and a hypervirulent strain, PCR ribotype 027/REA type BI/North American pulsed-field (NAP) type 1 (027/BI/NAP-1), has caused outbreaks in North America and Europe. In contrast, only a few reports of cases in Latin America have been published and the hypervirulent strain 027/BI/NAP-1 has, so far, only been reported in Costa Rica. The potential worldwide spread of this infection calls for epidemiological studies to characterize currently circulating strains and also highlights the need for increased awareness and vigilance among healthcare professionals in currently unaffected areas, such as Latin America. This review attempts to summarize reports of infection worldwide, especially in Latin America, and aims to provide an introduction to the problems associated with this pathogen for those countries that might face outbreaks of epidemic strains of for the first time in the near future.

  • This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.037077-0
2012-02-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jmm/61/2/169.html?itemId=/content/journal/jmm/10.1099/jmm.0.037077-0&mimeType=html&fmt=ahah

References

  1. Alcides A. P., Brazier J. S., Pinto L. J., Balassiano I. T., Boente R. F., de Paula G. R., Ferreira E. O., Avelar K. E., Miranda K. R. other authors 2007; New PCR ribotypes of Clostridium difficile detected in children in Brazil: prevalent types of Clostridium difficile in Brazil. Antonie van Leeuwenhoek 92:53–59 [View Article][PubMed]
    [Google Scholar]
  2. Alfa M. J., Kabani A., Lyerly D., Moncrief S., Neville L. M., Al-Barrak A., Harding G. K., Dyck B., Olekson K., Embil J. M. 2000; Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea. J Clin Microbiol 38:2706–2714[PubMed]
    [Google Scholar]
  3. Alvarez M., González R., Briceño I., Cofre C., Labarca J., Vial P., García P. 2001; [Diagnosis of Clostridium difficile diarrhea: in search of a more efficient clinical focus]. Rev Med Chil 129:620–625 (in Spanish) [PubMed] [CrossRef]
    [Google Scholar]
  4. Bacci S., St-Martin G., Olesen B., Bruun B., Olsen K. E., Nielsen E. M., Mølbak K. 2009; Outbreak of Clostridium difficile 027 in North Zealand, Denmark, 2008–2009. Euro Surveill 14:pii:19183 Available online http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19183
    [Google Scholar]
  5. Balassiano I. T., Miranda K. R., Boente R. F., Pauer H., Oliveira I. C., Santos-Filho J., Amorim E. L., Caniné G. A., Souza C. F., Gomes M. Z. R. 2009; Characterization of Clostridium difficile strains isolated from immunosuppressed inpatients in a hospital in Rio de Janeiro, Brazil. Anaerobe 15:61–64 [View Article][PubMed]
    [Google Scholar]
  6. Balassiano I. T., Dos Santos-Filho J., de Oliveira M. P., Ramos M. C., Japiassu A. M., Dos Reis A. M., Brazier J. S., de Oliveira Ferreira E., Domingues R. M. C. P. 2010; An outbreak case of Clostridium difficile-associated diarrhea among elderly inpatients of an intensive care unit of a tertiary hospital in Rio de Janeiro, Brazil. Diagn Microbiol Infect Dis 68:449–455 [View Article][PubMed]
    [Google Scholar]
  7. Balassiano I. T., Santos-Filho J., Vital-Brazil J. M., Nouér S. A., Souza C. R., Brazier J. S., de O. Ferreira E. O., Domingues R. M. C. P. 2011; Detection of cross-infection associated to a Brazilian PCR-ribotype of Clostridium difficile in a university hospital in Rio de Janeiro, Brazil. Antonie van Leeuwenhoek 99:249–255 [View Article][PubMed]
    [Google Scholar]
  8. Baldan R., Cavallerio P., Tuscano A., Parlato C., Fossati L., Moro M., Serra R., Cirillo D. M. 2010; First report of hypervirulent strains polymerase chain reaction ribotypes 027 and 078 causing severe Clostridium difficile infection in Italy. Clin Infect Dis 50:126–127 [View Article][PubMed]
    [Google Scholar]
  9. Barbut F., Mastrantonio P., Delmée M., Brazier J., Kuijper E., Poxton I. on behalf of the European Study Group on Clostridium difficile (ESGCD) 2007; Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates. Clin Microbiol Infect 13:1048–1057 [View Article][PubMed]
    [Google Scholar]
  10. Bianco M., Fedele G., Quattrini A., Spigaglia P., Barbanti F., Mastrantonio P., Ausiello C. M. 2011; Immunomodulatory activities of surface-layer proteins obtained from epidemic and hypervirulent Clostridium difficile strains. J Med Microbiol 60:1162–1167 [View Article][PubMed]
    [Google Scholar]
  11. Borriello S. P., Welch A. R., Barclay F. E., Davies H. A. 1988; Mucosal association by Clostridium difficile in the hamster gastrointestinal tract. J Med Microbiol 25:191–196 [View Article][PubMed]
    [Google Scholar]
  12. Borriello S. P., Davies H. A., Kamiya S., Reed P. J., Seddon S. 1990; Virulence factors of Clostridium difficile . Rev Infect Dis 12:Suppl. 2S185–S191 [View Article][PubMed]
    [Google Scholar]
  13. Brazier J. S., Patel B., Pearson A. 2007; Distribution of Clostridium difficile PCR ribotype 027 in British hospitals. Euro Surveill 12:E070426–, 2[PubMed]
    [Google Scholar]
  14. Camacho-Ortiz A., Galindo-Fraga A., Rancel-Cordero A., Macías A. E., Lamothe-Molina P., Ponce de León-Garduño A., Sifuentes-Osornio J. 2009a; [Factors associated with Clostridium difficile disease in a tertiary-care medical institution in Mexico: a case-control study]. Rev Invest Clin 61:371–377 (in Spanish) [PubMed]
    [Google Scholar]
  15. Camacho-Ortiz A., Ponce-de-León A., Sifuentes-Osornio J. 2009b; [Clostridum difficile associated disease in Latin America]. Gac Med Mex 145:223–229 (in Spanish) [PubMed]
    [Google Scholar]
  16. Carrer M., Vázquez G. J., Lebrón R. I., Mercado X., Martínez I., Vázquez C. O., Santé M., Robledo I. E. 2005; The microbial etiologies of diarrhea in hospitalized patients from the Puerto Rico Medical Center Hospitals. P R Health Sci J 24:41–44[PubMed]
    [Google Scholar]
  17. Carter G. P., Lyras D., Allen D. L., Mackin K. E., Howarth P. M., O’Connor J. R. Jr, Rood J. I. 2007; Binary toxin production in Clostridium difficile is regulated by CdtR, a LytTR family response regulator. J Bacteriol 189:7290–7301 [View Article][PubMed]
    [Google Scholar]
  18. Cohen S. H., Tang Y. J., Silva J. Jr 2000; Analysis of the pathogenicity locus in Clostridium difficile strains. J Infect Dis 181:659–663 [View Article][PubMed]
    [Google Scholar]
  19. Dallal R. M., Harbrecht B. G., Boujoukas A. J., Sirio C. A., Farkas L. M., Lee K. K., Simmons R. L. 2002; Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg 235:363–372 [View Article][PubMed]
    [Google Scholar]
  20. Denève C., Janoir C., Poilane I., Fantinato C., Collignon A. 2009; New trends in Clostridium difficile virulence and pathogenesis. Int J Antimicrob Agents 33:Suppl. 1S24–S28 [View Article][PubMed]
    [Google Scholar]
  21. Dias M. B. S., Yamashiro J., Borrasca V. L., Stempliuk V. A., Araújo M. R. E., Costa S. F., Levin A. S. 2010; Pseudo-outbreak of Clostridium difficile associated diarrhea (CDAD) in a tertiary-care hospital. Rev Inst Med Trop Sao Paulo 52:133–137 [View Article][PubMed]
    [Google Scholar]
  22. Dillon S. T., Rubin E. J., Yakubovich M., Pothoulakis C., LaMont J. T., Feig L. A., Gilbert R. J. 1995; Involvement of Ras-related Rho proteins in the mechanisms of action of Clostridium difficile toxin A and toxin B. Infect Immun 63:1421–1426[PubMed]
    [Google Scholar]
  23. Drudy D., Fanning S., Kyne L. 2007; Toxin A-negative, toxin B-positive Clostridium difficile . Int J Infect Dis 11:5–10 [View Article][PubMed]
    [Google Scholar]
  24. Elliott B., Squire M. M., Thean S., Chang B. J., Brazier J. S., Rupnik M., Riley T. V. 2011; New types of toxin A-negative, toxin B-positive strains among clinical isolates of Clostridium difficile in Australia. J Med Microbiol 60:1108–1111 [View Article][PubMed]
    [Google Scholar]
  25. Eveillard M., Fourel V., Bare M. C., Kernéis S., Coconnier M. H., Karjalainen T., Bourlioux P., Servin A. L. 1993; Identification and characterization of adhesive factors of Clostridium difficile involved in adhesion to human colonic enterocyte-like Caco-2 and mucus-secreting HT29 cells in culture. Mol Microbiol 7:371–381 [View Article][PubMed]
    [Google Scholar]
  26. Fawley W. N., Underwood S., Freeman J., Baines S. D., Saxton K., Stephenson K., Owens R. C. Jr, Wilcox M. H. 2007; Efficacy of hospital cleaning agents and germicides against epidemic Clostridium difficile strains. Infect Control Hosp Epidemiol 28:920–925 [View Article][PubMed]
    [Google Scholar]
  27. Fernandez Canigia L., Nazar J., Arce M., Dadamio J., Smayevsky J., Bianchini H. 2001; [Clostridium difficile diarrhea: frequency of detection in a medical center in Buenos Aires, Argentina]. Rev Argent Microbiol 33:101–107 (in Spanish) [PubMed]
    [Google Scholar]
  28. Ferreira C. E., Nakano V., Durigon E. L., Avila-Campos M. J. 2003; Prevalence of Clostridium spp. and Clostridium difficile in children with acute diarrhea in São Paulo city, Brazil. Mem Inst Oswaldo Cruz 98:451–454 [View Article][PubMed]
    [Google Scholar]
  29. Freeman J., Bauer M. P., Baines S. D., Corver J., Fawley W. N., Goorhuis B., Kuijper E. J., Wilcox M. H. 2010; The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev 23:529–549 [View Article][PubMed]
    [Google Scholar]
  30. García C., Samalvides F., Vidal M., Gotuzzo E., Dupont H. L. 2007a; Epidemiology of Clostridium difficile-associated diarrhea in a Peruvian tertiary care hospital. Am J Trop Med Hyg 77:802–805[PubMed]
    [Google Scholar]
  31. García C., Velarde J., Cedron H., Ferrufino J. C., Seas C., Bussalleu A., Gotuzzo E., Gotuzzo E. 2007b; [Clostridium difficile and cytomegalovirus involved in a case of pseudomembranous colitis]. Rev Gastroenterol Peru 27:408–410 (in Spanish) [PubMed]
    [Google Scholar]
  32. García-Osogobio S., Takahashi T., Gamboa-Domínguez A., Medina H., Arch J., Mass W., Sierra-Madero J., Uscanga L. 2000; Toxic pseudomembranous colitis in a patient with ulcerative colitis. Inflamm Bowel Dis 6:188–190 [View Article][PubMed]
    [Google Scholar]
  33. Gardilcic M. F., Fica A. C., Chang M. R., Llanos C. M., Luzoro A. V. 2000; Diarrea asociada a Clostridium difficile en un hospital de adultos: estudio descriptivo. Rev Chil Infectol 17:307–312 [CrossRef]
    [Google Scholar]
  34. Geric B., Rupnik M., Gerding D. N., Grabnar M., Johnson S. 2004; Distribution of Clostridium difficile variant toxinotypes and strains with binary toxin genes among clinical isolates in an American hospital. J Med Microbiol 53:887–894 [View Article][PubMed]
    [Google Scholar]
  35. Gonçalves C., Decré D., Barbut F., Burghoffer B., Petit J. C. 2004; Prevalence and characterization of a binary toxin (actin-specific ADP-ribosyltransferase) from Clostridium difficile . J Clin Microbiol 42:1933–1939 [View Article][PubMed]
    [Google Scholar]
  36. Goorhuis A., Legaria M. C., van den Berg R. J., Harmanus C., Klaassen C. H. W., Brazier J. S., Lumelsky G., Kuijper E. J. 2009; Application of multiple-locus variable-number tandem-repeat analysis to determine clonal spread of toxin A-negative Clostridium difficile in a general hospital in Buenos Aires, Argentina. Clin Microbiol Infect 15:1080–1086 [View Article][PubMed]
    [Google Scholar]
  37. Graf K., Cohrs A., Gastmeier P., Kola A., Vonberg R. P., Mattner F., Sohr D., Chaberny I. F. 2009; An outbreak of Clostridium difficile-associated disease (CDAD) in a German university hospital. Eur J Clin Microbiol Infect Dis 28:543–545 [View Article][PubMed]
    [Google Scholar]
  38. Gravel D., Miller M., Simor A., Taylor G., Gardam M., McGeer A., Hutchinson J., Moore D., Kelly S. other authors 2009; Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study. Clin Infect Dis 48:568–576 [View Article][PubMed]
    [Google Scholar]
  39. Hall A. 1998; Rho GTPases and the actin cytoskeleton. Science 279:509–514 [View Article][PubMed]
    [Google Scholar]
  40. Herrera P., Cotera A., Fica A., Galdo T., Alvo M. 2003; [High incidence and complications of Clostridium difficile diarrhea among patients with renal diseases]. Rev Med Chil 131:397–403 (in Spanish) [PubMed]
    [Google Scholar]
  41. Hookman P., Barkin J. S. 2009; Clostridium difficile associated infection, diarrhea and colitis. World J Gastroenterol 15:1554–1580 [View Article][PubMed]
    [Google Scholar]
  42. Huang H., Weintraub A., Fang H., Nord C. E. 2009; Antimicrobial resistance in Clostridium difficile . Int J Antimicrob Agents 34:516–522 [View Article][PubMed]
    [Google Scholar]
  43. Jensen W., Moreno J. A., Marin S., Ahumada R., Huilcaman M., Joyas A. 2010; Caracterización de los pacientes con diarrea asociada a Clostridium difficile en el Hospital Dr Gustavo Fricke entre los años 2003–2008. Bol Hosp Viña del Mar 66:2–11
    [Google Scholar]
  44. Just I., Wilm M., Selzer J., Rex G., von Eichel-Streiber C., Mann M., Aktories K. 1995; The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins. J Biol Chem 270:13932–13936 [View Article][PubMed]
    [Google Scholar]
  45. Kato H., Kato N., Watanabe K., Iwai N., Nakamura H., Yamamoto T., Suzuki K., Kim S. M., Chong Y., Wasito E. B. 1998; Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR. J Clin Microbiol 36:2178–2182[PubMed]
    [Google Scholar]
  46. Kato H., Kato N., Katow S., Maegawa T., Nakamura S., Lyerly D. M. 1999; Deletions in the repeating sequences of the toxin A gene of toxin A-negative, toxin B-positive Clostridium difficile strains. FEMS Microbiol Lett 175:197–203 [View Article][PubMed]
    [Google Scholar]
  47. Kato H., Ito Y., van den Berg R. J., Kuijper E. J., Arakawa Y. 2007; First isolation of Clostridium difficile 027 in Japan. Euro Surveill 12:pii: 3110. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=3110[PubMed]
    [Google Scholar]
  48. Kuijper E. J., Coignard B., Brazier J. S., Suetens C., Drudy D., Wiuff C., Pituch H., Reichert P., Schneider F. other authors 2007; Update of Clostridium difficile-associated disease due to PCR ribotype 027 in Europe. Euro Surveill 12:E1–E2[PubMed]
    [Google Scholar]
  49. Kyne L., Hamel M. B., Polavaram R., Kelly C. P. 2002; Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile . Clin Infect Dis 34:346–353 [View Article][PubMed]
    [Google Scholar]
  50. Leclair M. A., Allard C., Lesur O., Pépin J. 2010; Clostridium difficile infection in the intensive care unit. J Intensive Care Med 25:23–30 [View Article][PubMed]
    [Google Scholar]
  51. Legaria M. C., Lumelsky G., Rosetti S. 2003; Clostridium difficile-associated diarrhea from a general hospital in Argentina. Anaerobe 9:113–116 [View Article][PubMed]
    [Google Scholar]
  52. Loo V. G., Poirier L., Miller M. A., Oughton M., Libman M. D., Michaud S., Bourgault A. M., Nguyen T., Frenette C. other authors 2005; A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 353:2442–2449 [View Article][PubMed]
    [Google Scholar]
  53. Lyras D., O’Connor J. R., Howarth P. M., Sambol S. P., Carter G. P., Phumoonna T., Poon R., Adams V., Vedantam G. other authors 2009; Toxin B is essential for virulence of Clostridium difficile . Nature 458:1176–1179 [View Article][PubMed]
    [Google Scholar]
  54. Marcon A. P., Gamba M. A., Vianna L. A. 2006; Nosocomial diarrhea in the intensive care unit. Braz J Infect Dis 10:384–389 [View Article][PubMed]
    [Google Scholar]
  55. McDonald L. C., Killgore G. E., Thompson A., Owens R. C. J. R. Jr, Kazakova S. V., Sambol S. P., Johnson S., Gerding D. N. 2005; An epidemic, toxin gene-variant strain of Clostridium difficile . N Engl J Med 353:2433–2441 [View Article][PubMed]
    [Google Scholar]
  56. McFarland L. V. 2009; Renewed interest in a difficult disease: Clostridium difficile infections – epidemiology and current treatment strategies. Curr Opin Gastroenterol 25:24–35 [View Article][PubMed]
    [Google Scholar]
  57. Mitty E. 2009; Infection control practices in assisted living communities. Geriatr Nurs 30:417–423 [View Article][PubMed]
    [Google Scholar]
  58. O’Connor J. R., Johnson S., Gerding D. N. 2009; Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology 136:1913–1924 [View Article][PubMed]
    [Google Scholar]
  59. Pépin J., Valiquette L., Alary M. E., Villemure P., Pelletier A., Forget K., Pépin K., Chouinard D. 2004; Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 171:466–472 [View Article][PubMed]
    [Google Scholar]
  60. Pinto L. J., Alcides A. P., Ferreira E. O., Avelar K. E., Sabrá A., Domingues R. M. C. P., Ferreira M. C. 2003; Incidence and importance of Clostridium difficile in paediatric diarrhoea in Brazil. J Med Microbiol 52:1095–1099 [View Article][PubMed]
    [Google Scholar]
  61. Popoff M. R., Rubin E. J., Gill D. M., Boquet P. 1988; Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain. Infect Immun 56:2299–2306 [View Article][PubMed]
    [Google Scholar]
  62. Poutanen S. M., Simor A. E. 2004; Clostridium difficile-associated diarrhea in adults. CMAJ 171:51–58 [View Article][PubMed]
    [Google Scholar]
  63. Quesada-Gómez C., Rodríguez C., Gamboa-Coronado M. M., Rodríguez-Cavallini E., Du T., Mulvey M. R., Villalobos-Zúñiga M., Boza-Cordero R. 2010; Emergence of Clostridium difficile NAP1 in Latin America. J Clin Microbiol 48:669–670 [View Article][PubMed]
    [Google Scholar]
  64. Riley T. V., Thean S., Hool G., Golledge C. L. 2009; First Australian isolation of epidemic Clostridium difficile PCR ribotype 027. Med J Aust 190:706–708[PubMed]
    [Google Scholar]
  65. Rupnik M., Kato N., Grabnar M., Kato H. 2003; New types of toxin A-negative, toxin B-positive strains among Clostridium difficile isolates from Asia. J Clin Microbiol 41:1118–1125 [View Article][PubMed]
    [Google Scholar]
  66. Rupnik M., Wilcox M. H., Gerding D. N. 2009; Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 7:526–536 [View Article][PubMed]
    [Google Scholar]
  67. Sambol S. P., Merrigan M. M., Lyerly D., Gerding D. N., Johnson S. 2000; Toxin gene analysis of a variant strain of Clostridium difficile that causes human clinical disease. Infect Immun 68:5480–5487 [View Article][PubMed]
    [Google Scholar]
  68. Sánchez-Pérez M., Muñoz-Juárez M., Luque-de León E., Moreno-Paquentin E., Cordera-González de Cosio F., Jean-Silver E. 2010; Toxic megacolon secondary to Clostridium difficile colitis. Case report. Rev Gastroenterol Mex 75:103–106[PubMed]
    [Google Scholar]
  69. Schroeder M. S. 2005; Clostridium difficile-associated diarrhea. Am Fam Physician 71:921–928[PubMed]
    [Google Scholar]
  70. Stubbs S. L. J., Brazier J. S., O’Neill G. L., Duerden B. I. 1999; PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol 37:461–463[PubMed]
    [Google Scholar]
  71. Tae C. H., Jung S. A., Song H. J., Kim S. E., Choi H. J., Lee M., Hwang Y., Kim H., Lee K. 2009; The first case of antibiotic-associated colitis by Clostridium difficile PCR ribotype 027 in Korea. J Korean Med Sci 24:520–524 [View Article][PubMed]
    [Google Scholar]
  72. Tan K. S., Wee B. Y., Song K. P. 2001; Evidence for holin function of tcdE gene in the pathogenicity of Clostridium difficile . J Med Microbiol 50:613–619[PubMed]
    [Google Scholar]
  73. Voth D. E., Ballard J. D. 2005; Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev 18:247–263 [View Article][PubMed]
    [Google Scholar]
  74. Wheeldon L. J., Worthington T., Hilton A. C., Elliott T. S., Lambert P. A. 2008; Physical and chemical factors influencing the germination of Clostridium difficile spores. J Appl Microbiol 105:2223–2230 [View Article][PubMed]
    [Google Scholar]
  75. Wilcox M. H., Fawley W. N. 2000; Hospital disinfectants and spore formation by Clostridium difficile . Lancet 356:1324 [View Article][PubMed]
    [Google Scholar]
  76. Zumbado-Salas R., Gamboa-Coronado M. del M., Rodríguez-Cavallini E., Chaves-Olarte E. 2008; Clostridium difficile in adult patients with nosocomial diarrhea in a Costa Rican hospital. Am J Trop Med Hyg 79:164–165[PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.037077-0
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error